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Abstract
Background: Germinated brown rice (GBR) is a novel functional food that is high in fiber and bioactive
compounds with health-promoting properties. This study aims to evaluate anti-obesity effects of GBR in obese rats
fed high-fat diet (HFD).
Methods: Male Sprague-Dawley rats were fed HFD for 8 weeks to induce obesity. The rats were then administrated
with GBR where the source of dietary carbohydrate of HFD was replaced by either 25 % GBR, 50 % GBR or 100 %
GBR for another 8 weeks. Changes in anthropometry, dietary status, biochemical parameters and histopathology of
liver and adipose tissue were measured.
Results: Rats fed with HFD were showed elevation in body weight gain and in white adipose tissue mass
compared with rats consumed commercial diet. The GBR administration in 50 % GBR and 100 % GBR were
significantly decreased body weight gains and food intakes as well as improved lipid profiles in obese rats. In
addition, the administration of GBR had reduced adiposity by showing declination in white adipose tissue mass,
adipocytes size and leptin level concomitantly with a higher ratio of fat excretion into feces. Micro- and
macrovesicular steatosis were evidently attenuated in obese rats fed GBR.
Conclusion: These findings demonstrated that GBR exhibited anti-obesity effects through suppression of body
weight gain and food intake, improvement of lipid profiles and reduction of leptin level and white adipose tissue
mass in obese rats fed HFD.
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Background
Obesity is a condition where abnormal or excessive fat
accumulation in the body may affect one person’s health
[1]. It is often considered to be a major health threat to
disorders such as diabetes mellitus, hypertension, dyslip-
idemia, coronary heart disease, stroke and several types
of cancer as well as increasing the risk of mortality [2].
Recently, about 10.0 % of world adults male and 14.0 %
of world adults female were identified as being obese
(body mass index, BMI ≥30) in the report of World
Health Statistics 2014 [3]. In Malaysia, the prevalence of
obese adults was 15.1 % in 2011 [4]. Due to the complex
etiology of obesity, therapeutic approaches for long-term
obesity management are difficult. Lifestyle intervention
includes lowering food intake and increasing physical
activity, the main therapeutic strategy for tackling obesity,
is usually not so promising, not long-term lasting and
require much discipline from the individuals [5]. Anti-
obesity drugs, in contrast, are able rapidly to induce
weight loss but accompany with adverse effects and user
may encounter the problem of regaining weight when
discontinued [6].
In recent years, researchers are showing much interest
in discovering non-drug strategies such as consuming
functional foods or nutraceuticals products as potential
therapeutic ways to combat obesity [7]. Numerous stud-
ies have examined the anti-obesity effects from various
rice species including geminated rough rice [8], germi-
nated brown rice (GBR) [9, 10], black rice [11], wild rice
[12] and red mold rice [13]. GBR particularly is quite
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popular in Asia. It is produced by soaking brown rice in
water to induce germination with the germ of about
1 mm long [14]. GBR is not only had intact germ and
bran layers that are rich in nutrients, but the hydrolytic
enzymes inside the seed have also been activated to pro-
duce essential compounds and energy for the formation
of seedling during germination [8]. For this reason, it is
rich in nutrients such as vitamins, minerals, fibers and
bioactive components like γ-aminobutyric acid (GABA),
γ-oryzanol and ferulic acid that give numerous protect-
ive health effects including antioxidants properties [15,
16], hypocholesterolemic effect [17, 18], hypoglycemic
effect [19], anti-colon cancer effect [14], improve Alzhei-
mer’s disease development [20], stimulate osteoblasto-
genesis [21], and alleviate reproductive system atrophy,
dryness and discomfort during menopause [22]. Besides,
compared to brown rice, the texture of GBR is found to
be less tough and thus better palatability [23].
Previous studies of methanol extract [9] and water ex-
tract [10] of GBR demonstrated suppression on body
weight gains on mice fed on HFD. Ho et al. [9] reported
that methanol extract of GBR was able to reduce adipo-
genesis in 3T3-L1 adipocytes through the down-
regulated expression of adipogenic transcription factors
and adipogenic genes. Although few studies have exam-
ined the different medicinal properties of GBR and its
protective effects in obesity, the information about the
use of GBR as a whole instead of extract as a nutraceut-
ical in obesity treatment remains limited. Thus, this
study was embarked to investigate the therapeutic effects




Brown rice (Oryza sativa MR220 & MR219), varieties
that commonly available in the market, was obtained
from Padiberas Nasional Berhad (Bernas), Malaysia. The
rice was germinated according to the pre-optimized con-
ditions established in Laboratory of Molecular Biomedi-
cine, Institute of Bioscience, Universiti Putra Malaysia
(UPM), Selangor, Malaysia as described previously [24].
The GBR was ground to powder using a stainless steel
blender (Waring Commercial, Torrington, CT, USA)
before used to make rat pellets. Based on our previous
study, GBR powder (per 100 g sample) was contained of
moisture, 14.04 g; fat, 2.11 g; protein, 11.03 g; carbohy-
drate, 54.30 g; dietary fiber, 9.18 g, and its energy
content was 390.95 ± 11.311 kcal [25].
Animals
Forty-six male Sprague-Dawley rats (166.02 ± 19.63 g)
were individually housed in polycarbonate cages (15 cm
x 25 cm) with stainless steel covers in the animal house
of Faculty of Medicine and Health Sciences, UPM with
controlled conditions (24 ± 2 °C, 85 % relative humidity
and a controlled 12 h light-dark cycle) throughout the
experiment. Male rats were selected to eliminate varia-
tions in food intake due to ovarian hormones [26], in
addition to their faster-growing degree than females,
which enable easier detection of changes in body weight
[27]. All rats were acclimatized for a week with the com-
mercial food pellets (Gold Coin, Port Klang, Malaysia).
The food pellet consisted of 13 % moisture, 8 % ash,
50 % carbohydrate, 21 % protein, 3 % fat and 5 % fiber.
Diets and distilled water were provided ad libitum to
rats all through the experiment. Experimental proce-
dures were obtained ethical clearance with reference No.
UPM/IACUC/AUP-R034/2014 and were conducted in
accordance with the guidelines established by the Insti-
tutional Animal Care and Use Committee of UPM.
Induction of obesity
Following acclimatization, the rats were randomly di-
vided into normal diet control (NC) group (n = 11) and
HFD group (n = 35). The NC group was continually on
commercial food pellets while the latter group was in-
duced obesity by feeding HFD for 8 weeks. The HFD
was formulated based on Levin et al. [28] with modifica-
tion. It was prepared from a mixture of 50 % commercial
food pellet, 24 % ghee, 20 % full-cream milk powder and
6 % corn starch. HFD was prepared weekly, to avoid
spoilage, by mixing all ingredients thoroughly, spread in
trays, cut into smaller pieces and placed in an oven at
65 °C for 24 h. It was stored at 4 °C to avoid lipid oxida-
tion. After the induction period, the mean body weights
of the HFD group rats were compared with the NC
group. Rats with more than 10 % body weights than the
maximum body weights of normal diet rats were consid-
ered as obese [29]. The obesity was also confirmed by
using Lee index. It was calculated by the cube root of
body weight (g)/nose-anal length (cm), for which a value
equal to or lower than 0.30 was classified as normal. For
value higher than 0.30, the rat was classified as obese
[30]. Three rats from NC group and HFD groups, re-
spectively, were sacrificed under anesthesia to obtain
data on their weight of adipose tissue. The adipose tissue
of HFD group rats should weigh 30–45 % more than
those of NC group rats [29].
Treatments of GBR
After confirming that the HFD rats were obese (8 weeks
of obesity induction), the rats were further subdivided
into HFD positive control (PC) group (n = 8), HFD-
induced obese rat administrated with 25 % GBR (25 T)
group (n = 8), HFD-induced obese rat administrated with
50 % GBR (50 T) group (n = 8), and HFD-induced obese
rat administrated with 100 % GBR (100 T) group (n = 8).
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Each of the group was provided with their respective di-
ets for another 8 weeks. The NC group (n = 8) was con-
tinually on commercial food pellets, the PC group was
on the formulated HFD, the 25 T group was received
formulated HFD in which 25 % of the commercial food
pellets was substituted with GBR, the 50 T group was re-
ceived formulated HFD in which 50 % of the commercial
food pellets was substituted with GBR, and the 100 T
group was received formulated HFD in which all of the
commercial food pellets was substituted with GBR.
Treatment diets were prepared in a similar way as for-
mulated HFD. The energy content of each diet was de-
termined by bomb calorimetry (IKA C5003, IKA Werke,
Germany) according to the manufacturer’s protocol and
expressed as kcal/100 g of sample.
Anthropometric and dietary measurements
The body weight of each rat was measured at weekly
intervals and food intake was recorded twice in a week
using electrical balance. The BMI was calculated as body
weight (g) divided by the square of the anal-nasal length
(cm). The feed efficiency was calculated as weight gain per
day (g) divided by either food intake per day (g) or energy
intake per day (kcal).
Blood and organ tissue collection
Blood samples were collected after an overnight fast
under ketamine and xylazine anesthesia during the end
of the induction and end of the treatment. The collected
blood was centrifuged for 10 min at 3500 rpm at room
temperature and the supernatants were collected and
kept at −80 °C. At the end of the treatment, rats were
exsanguinated through cardiac puncture. The liver was
surgically removed, rinsed with physiological saline solu-
tion and wet weights were measured with an analytical
balance after blotting. The white adipose tissues (abdom-
inal, epididymal and perirenal) were dissected and wet
weights were recorded.
Biochemical analysis
Plasma of total cholesterol, triglyceride and high-
density lipoprotein (HDL) cholesterol were mea-
sured using enzymatic colorimetric method (Cobas
8000, Roche-Diagnostics, Basel, Switzerland). Fasting
blood glucose level was analyzed by UV-Test with
hexokinase reference method (Cobas 8000, Roche-
Diagnostics, Basel, Switzerland). Plasma leptin
concentration was quantified using the enzyme-
linked immunosorbent assay (ELISA) kits according
to as described in the manufacturer’s instruction
(Catalog No. CSB-E07433r, CUSABIO BIOTECH
CO., LTD, China).
Fecal fat content analysis
Feces were collected from rats on 7 consecutive days on
the last week of obesity induction and on the last week
end of the treatment. They were freeze dried and ground
by mortar and pestle before being analyzed using a soxh-
let extraction apparatus (Soxtec Avanti 2050, Foss Teca-
tor AB, Hoganas, Sweden) with petroleum ether. The
fecal fat content is expressed as the percentage of fat.
Histopathological studies of liver and white adipose
tissue
The liver and white adipose tissues were fixed in a buffer
solution of 10 % formalin. The fixed tissues were
processed routinely for paraffin embedding, after which
4–5 μm sections were prepared and stained with
hematoxylin and eosin (H&E). The stained areas were
then viewed using an optical microscope.
Statistical analysis
Data are expressed as means ± standard deviations (SD).
Analyzes were performed by one-way analysis of vari-
ance (ANOVA), followed by Duncan’s multiple-range
test, using IBM SPSS software version 21.0. Paired sam-
ple T-test (two tails) was performed to compare the
results obtained before treatment and after treatment
within same groups whereas Independent sample T-test
(two tails) was performed to compare the results
obtained between two groups. Values were considered
statistically significant when p < 0.05.
Results
Energy distribution of each diet
Table 1 shows the energy distribution in the percentage
of different diets fed to the rats. HFD indicated the high-
est energy content (560.13 ± 4.17 kcal/100 g) and was
used to induce obesity among HFD group for 8 weeks.
Energy contributed from fat sources in HFD diet was
52.0 kcal% and it was 43 % increase fat composition
compared with normal diet (9.0 kcal%). The energy con-
tent of the normal diet was only 389.74 ± 1.11 kcal/100 g
in which carbohydrate was contributed the highest en-
ergy with 64.0 kcal%. For treatment groups, energy con-
tent was 532.58 ± 9.91 kcal/100 g for 25 T (HFD + 25 %
GBR), 528.63 ± 4.51 kcal/100 g for 50 T (HFD + 50 %
GBR) and 544.30 ± 4.03 kcal/100 g for 100 T (HFD +
100 % GBR). Energy contributed by fat was 52.0 kcal%
in all treatment diets.
Anthropometry, dietary status, and weight of organs and
white adipose tissue measurement during obesity
induction period
The anthropometry, dietary status, and weight of organs
and white adipose tissue during obesity induction period
are shown in Table 2. The body weight gains of the HFD
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group were significantly higher (p < 0.05) than the NC
group although their body weights were similar at the
onset of the experiment. Similarly, significantly higher
(p < 0.05) Lee index and BMI were observed in the HFD
group compared with the NC group. No significant dif-
ference in food intake was observed throughout the
obesity induction period in both groups. However, the
energy intake and feed efficiency indicated significantly
higher value (p < 0.05) in the HFD group compared with
the NC group.
No significant difference was observed in liver and
kidney weights normalized to 100 g of body weight
between the HFD group and the NC group. However,
with regard to white adipose tissue, the weights of ab-
dominal, epididymal and perirenal in rats fed on HFD
were significantly higher (p < 0.05) compared with the
NC group rats. The total white adipose tissue weights of
rats fed on HFD was increased 86.42 % compared with
the NC group rats. The adipose tissue weight gains of
abdominal, epididymal and perirenal were increased
78.44, 43.12, and 10.78 % compared with the NC group,
respectively.
Anthropometry, dietary status, and weight of organs and
white adipose tissue measurement during treatment
period
Figure 1 (a) shows the changes of body weights of rats
during the 8 weeks treatment period. The body weights
of the rats increased gradually during the treatment
period in all groups except in the 100 T group where the
body weights in this group were relatively consistent.
GBR administration for 8 weeks significantly decreased
(p < 0.05) body weight gains in the 100 T group (16.88 ±
10.12 g) and 50 T group (91.50 ± 23.24 g) as compared
with the PC group (135.63 ± 34.04 g) as shown in Table 3.
The Lee index and BMI in these two groups were also
significantly lower (p < 0.05) than the PC group. The
mean body weight gains in the 100 T group were notably
lower compared with the NC group although they were
fed on HFD. The changes in food intakes during the
treatment period are shown in Fig. 1 (b). Similarly, the
food intakes were significantly lower (p < 0.05) in the
50 T group and the 100 T group compared with other
groups. There was no significant difference in food in-
takes between the PC group (15.29 ± 1.11 g) and the NC
group (15.38 ± 1.02 g). At the same time, the administra-
tion of GBR significantly reduced (p < 0.05) energy in-
take in the 25 T, 50 T, and the 100 T group as compared
with the PC group in a dose-dependent manner al-
though all of these groups were fed on HFD. The feed
efficiency of the 50 T group and the 100 T group were
significantly lower (p < 0.05) than the PC group but the
feed efficiency of the 25 T group was comparable with
the PC group.
Table 1 Energy distribution in percentage of each diet in the experiment
Type of diet1 Normal diet2 HFD HFD + 25 % GBR HFD + 50 % GBR HFD + 100 % GBR
Protein (kcal%) 27.0 13.0 13.0 12.0 10.0
Carbohydrate (kcal%) 64.0 35.0 35.0 36.0 38.0
Fat (kcal%) 9.0 52.0 52.0 52.0 52.0
Total energy (kcal/100 g)2 389.74 ± 1.11a 560.13 ± 4.17b 532.58 ± 9.91c 528.63 ± 4.51c 544.30 ± 4.03d
Values with different superscripts in a row indicate significant difference (p < 0.05) by Duncan’s multiple range tests
HFD high fat diet, GBR germinated brown rice
1Values are calculated from total energy while total energy was determined by bomb calorimetry (IKA C5003, IKA Werke, Germany)
2Commercial food pellets from Gold Coin, Port Klang, Malaysia
Table 2 Anthropometry, dietary status, and weight of organs
and white adipose tissues during obesity induction period by
high fat diet in rats
Groups NC1 HFD2
Body weight (g)
Initial 221.36 ± 24.33a 218.86 ± 21.10a
Final 335.09 ± 19.28a 420.70 ± 41.71b
Body weight gain (g) 113.73 ± 15.88a 202.61 ± 34.50b
Lee index 0.29 ± 0.00a 0.31 ± 0.00b
Body mass index 0.60 ± 0.02a 0.70 ± 0.04b
Food intake (g/day/rat) 15.80 ± 4.48a 16.44 ± 1.10a
Energy intake (kcal/day/rat) 61.63 ± 17.46a 89.03 ± 7.27b
Feed efficiency (g/g) 0.13 ± 0.02a 0.22 ± 0.04b
Feed efficiency (g/kcal) 0.03 ± 0.00a 0.04 ± 0.01b
Groups NC3 HFD3
Organ weight (g/100 g BW)
Liver 2.26 ± 0.05a 2.75 ± 0.21a
Kidney 0.32 ± 0.01a 0.33 ± 0.00a
White adipose tissue weight
(g/100 g BW)
0.66 ± 0.09a 4.86 ± 0.25b
Abdominal 0.58 ± 0.02a 2.69 ± 0.29b
Epididymal 0.53 ± 0.13a 1.69 ± 0.17b
Perirenal 0.19 ± 0.05a 0.48 ± 0.07b
Values with different superscripts in a row indicate significant difference (p <
0.05) by Independent-Samples T test
NC normal diet, HFD high-fat diet
1 Values are expressed as means ± SD (n = 11)
2 Values are expressed as means ± SD (n = 35)
3 Values are expressed as means ± SD (n = 3)
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The liver weights of the HFD groups (PC, 25, 50, and
100 T) were significantly higher compared with the NC
group. The rats administrated with GBR were showed
lower liver weights than the PC group although no sig-
nificant difference was observed among them. The kid-
ney weights were comparable between the HFD groups
and the NC group. Rats fed on HFD showed significant
increased (p < 0.05) in weight of all three types of white
adipose tissues compared with the NC group. Only rats
fed with the highest dose of GBR (100 T) was showed a
significantly lower amount of total white adipose tissue
(4.55 ± 1.31 g/100 g BW) compared with the PC group
(5.75 ± 1.18 g/100 g BW). However, no significant differ-
ence was observed in individual weight of abdominal,
epididymal and perirenal adipose tissue between the
100 T group and the PC group.
Changes of biochemical analysis
Table 4 shows the changes of plasma lipid profiles, glu-
cose levels and leptin levels between induction and treat-
ment period in rats. Rats fed on HFD for 8 weeks
demonstrated significant elevation (p < 0.05) of total
cholesterol levels and triglyceride levels compared with
the NC group. However, the feeding of GBR to obese
rats (25, 50, and 100 T) resulted in significant reduction
(p < 0.05) of the total cholesterol levels as compared with
the PC group and with their respectively total choles-
terol levels before treatment. The triglyceride levels were
significantly lower (p < 0.05) in the 50 T group (90.67 ±
11.99 mg/dL) and 100 T group (87.91 ± 11.78 mg/dL)
compared with the PC group (143.59 ± 20.60 mg/dL).
However, the reduction of triglyceride levels was not sig-
nificantly difference compared with their respective
A
B
Fig. 1 Effects of GBR on body weight and food intake of rats during the 8 weeks treatment period. a Changes of body weight. b Changes of
food intake. Values are expressed as means ± SD (n = 8). NC, normal diet; PC, high-fat diet; 25 T, high-fat diet + 25 % GBR; 50 T, high-fat diet +
50 % GBR; 100 T, high-fat diet + 100 % GBR
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triglyceride levels before treatment. Although the admin-
istration of GBR in obese rats did not increase HDL-
cholesterol levels, it was observed that the administra-
tion of GBR reduced the declination of plasma HDL-
cholesterol levels with only 15.02 % reduction in the
50 T group and 12.66 % reduction in the 100 T group
compared with 33.00 % reduction in the PC group.
Overall, the administration of GBR improved the plasma
lipid profiles in treated obese rats, which was also shown
by an increment of HDL-cholesterol/total cholesterol
ratio (HTR) compared with untreated obese rats. The
HTR was found to be increased in the 50 T group
(5.00 %) and the 100 T group (8.65 %) after GBR treatment
while the HTR were decreased in the NC group ( −3.62 %),
25 T group ( −3.90 %) and PC group ( −50.97 %) after treat-
ment. In addition, the atherogenic index (AI) was found to
be significantly decreased (p < 0.05) in all GBR adminis-
trated groups compared with the PC group. A significant
Table 3 Anthropometry, dietary status, and weight of organs and white adipose tissues during GBR treatment period in
diet-induced obese rats
Groups NC PC 25 T 50 T 100 T
Body weight (g)
Initial 328.25 ± 23.30a 427.25 ± 57.91b 414.25 ± 27.91b 403.00 ± 33.56b 400.88 ± 29.68b
Final 370.63 ± 29.12a 562.88 ± 85.62b 548.50 ± 43.27bc 494.50 ± 59.58c 417.75 ± 45.47a
Body weight gain (g) 42.38 ± 14.73a 135.63 ± 34.04b 134.25 ± 20.49b 91.50 ± 23.24c 16.88 ± 10.12a
Lee index 0.29 ± 0.00a 0.32 ± 0.01b 0.31 ± 0.00b 0.31 ± 0.01c 0.30 ± 0.01a
Body mass index 0.62 ± 0.03a 0.82 ± 0.06b 0.81 ± 0.04b 0.74 ± 0.06c 0.67 ± 0.06d
Food intake (g/day/rat) 15.38 ± 1.02a 15.29 ± 1.11a 15.30 ± 0.73a 14.57 ± 0.61b 12.00 ± 0.86c
Energy intake (kcal/day/rat) 59.96 ± 4.00a 85.64 ± 6.21b 81.53 ± 3.89c 77.07 ± 3.24d 65.26 ± 4.67e
Feed efficiency (g/g) 0.06 ± 0.02a 0.16 ± 0.04b 0.16 ± 0.02b 0.11 ± 0.03c 0.04 ± 0.01a
Feed efficiency (g/kcal) 0.01 ± 0.00a 0.03 ± 0.01b 0.03 ± 0.00b 0.02 ± 0.01ab 0.01 ± 0.00a
Organ weight (g/100 g BW)
Liver 2.43 ± 0.21a 2.89 ± 0.20b 2.84 ± 0.23b 2.82 ± 0.20b 2.70 ± 0.25b
Kidney 0.46 ± 0.04ab 0.47 ± 0.02b 0.44 ± 0.03ab 0.44 ± 0.04ab 0.43 ± 0.03a
White adipose tissue weight (g/100 g BW) 1.45 ± 0.91a 5.75 ± 1.18b 5.59 ± 0.47bc 4.97 ± 1.28bc 1.31c
Abdominal 0.67 ± 0.55a 3.51 ± 0.65b 3.44 ± 0.40b 3.11 ± 0.78b 0.99b
Epididymal 0.57 ± 0.19a 1.71 ± 0.51b 1.70 ± 0.31b 1.42 ± 0.53b 1.28 ± 0.50b
Perirenal 0.21 ± 0.07a 0.53 ± 0.13b 0.45 ± 0.10b 0.43 ± 0.17b 0.40 ± 0.13ab
Values are expressed as means ± SD (n = 8)
Values with different superscripts in a row indicate significant difference (p < 0.05) by Duncan’s multiple range tests
NC normal diet, PC high-fat diet, 25 T high-fat diet + 25 % GBR, 50 T high-fat diet + 50 % GBR, 100 T high-fat diet + 100 % GBR









NC Induction 53.61 ± 9.56Aa 46.94 ± 9.19Aa 40.02 ± 4.63Aa 75.48 ± 6.38Aa 0.33 ± 0.12Aa 121.62 ± 7.64Aa 3.59 ± 0.42Aa
Treatment 57.57 ± 10.64Aa 59.56 ± 7.33Ba 40.70 ± 6.01Aa 71.77 ± 9.91Aa 0.35 ± 0.11Aa 130.18 ± 5.76Ba 3.65 ± 0.43Aa
PC Induction 66.80 ± 7.48Ab 99.53 ± 12.67Ab 46.55 ± 8.75Aab 69.28 ± 6.56Aab 0.45 ± 0.14Aa 125.90 ± 12.61Aa 4.65 ± 0.62Ab
Treatment 76.37 ± 7.95Bb 143.59 ± 20.60Bb 35.00 ± 7.10Ba 45.89 ± 8.79Bb 1.17 ± 0.39Bb 138.29 ± 10.93Bb 4.97 ± 0.75Ab
25 T Induction 65.40 ± 9.79Ab 96.10 ± 14.90Ab 48.77 ± 9.75Ab 74.34 ± 7.17Aab 0.39 ± 0.16Aa 115.77 ± 14.41Aa 4.78 ± 0.55Ab
Treatment 49.40 ± 5.47Ba 127.43 ± 7.20Bc 34.85 ± 3.06Ba 71.44 ± 11.42Aa 0.45 ± 0.15Aa 114.64 ± 4.30Ac 4.57 ± 0.35Ab
50 T Induction 72.55 ± 11.55Ab 100.42 ± 9.68Ab 47.03 ± 5.41Aab 65.89 ± 10.79Ab 0.45 ± 0.18Aa 117.79 ± 8.88Aa 4.63 ± 0.51Ab
Treatment 59.60 ± 12.70Ba 90.67 ± 11.99Ad 40.89 ± 9.74Aa 69.36 ± 14.19Aa 0.35 ± 0.18Aa 116.67 ± 2.68Ac 4.44 ± 0.60Ab
100 T Induction 72.84 ± 6.51Ab 99.75 ± 11.08Ab 46.89 ± 5.12Aab 65.09 ± 10.72Ab 0.49 ± 0.19Aa 113.29 ± 11.49Aa 4.68 ± 1.02Ab
Treatment 57.86 ± 9.19Ba 87.91 ± 11.78Ad 41.62 ± 10.03Aa 71.25 ± 9.59Aa 0.32 ± 0.07Aa 112.61 ± 4.41Ac 4.33 ± 0.73Ab
NC normal diet, PC high-fat diet, 25 T high-fat diet + 25 % GBR, 50 T high-fat diet + 50 % GBR, 100 T high-fat diet + 100 % GBR
1HTR = (HDL-cholesterol/total cholesterol) × 100
2AI atherogenic index = (total cholesterol - HDL-cholesterol)/HDL-cholesterol
Block letters indicate significant difference (p < 0.05) within the same group at different time intervals by Paired sample T-test, while lower case letters indicate
significant difference (p < 0.05) between groups regarding the corresponding time interval by Duncan’s multiple range tests
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reduction (p < 0.05) of AI was observed in the 50 T group
and 100 group compared with their respective AI before
treatment. On the other hand, there was no significant dif-
ference in glucose levels between induction and treatment
in obese rats fed with GBR (25, 50, and 100 T). However,
the glucose levels of the NC group and PC group were
found to increase significantly (p < 0.05) compared with
their respectively glucose levels before treatment. Thus, this
indicated that GBR might help to mitigate the effect of
HFD on glucose level. Besides, the feeding of HFD for
8 weeks was significantly increased (p < 0.05) the leptin
levels in the HFD group compared with the NC group. The
leptin levels were found to be decreased but not signifi-
cantly different in the treatment groups (25, 50, and 100 T)
compared with their respectively leptin levels before treat-
ment. Oppositely, the leptin levels were found to be in-
creased in the NC group and the PC group after treatment.
Fecal fat content analysis
Figure 2 shows the fecal fat content of rats during obes-
ity induction period and treatment period. No significant
difference in the fecal fat content of rats was observed
between induction and treatment period for the NC
group and the PC group. However, the fecal fat content
was found to be increased significantly (p < 0.05) in rats
administrated with GBR in a dose-dependent manner
compared with the PC group and their respective fecal
fat content during induction. The fecal fat content was
found to be the highest in the 100 T group (5.72 ±
0.08 %), followed by 50 T group (3.18 ± 0.05 %) and 25 T
group (2.74 ± 0.08 %).
Histopathological studies of liver and white adipose
tissues
As shown in Fig. 3(a), the liver of NC group showed
normal lobular architecture with normal hepatocytes
arranged in one cell plate separated by sinusoids. GBR
administration reduced micro- and macrovesicular stea-
tosis as compared with untreated obese rats. The liver of
the PC group exhibited severe and diffuse micro- and
macrovesicular steatosis (Fig. 3(b)), whereas mild and
focal micro- and macrovesicular steatosis were observed
in the obese rats administrated with GBR (Fig. 3(c–e)).
Necrosis was also evidenced in the PC group but none
in the GBR administrated obese rats. No hepatitis,
hemorrhage, and perivenular fibrosis were observed in
all rats. Overall, histopathological analysis and their
qualitative scoring are summarized in Table 5.
White adipose tissues of the various groups of rats
are shown in Fig. 4(a–e). Routine processing methods
for microscopy generally extract lipid from tissues leav-
ing the lipid droplets within cells appear as unstained
vacuoles. The white adipose tissue exhibited larger adi-
pocytes in the PC group (Fig. 4(b)), whereas the NC
group showed normal adipocytes distribution with regu-
lar sizes of cells (Fig. 4 (a)). The fat stored in adipocytes
in obese rats especially the not administrated rats were
accumulated as lipid droplets which fuse to form a single
large droplet which distends and occupies most of the
cytoplasm. However, the adipocytes of obese rats treated
with GBR indicated smaller sizes and similar histology
to the NC group especially in the 100 T group rats
(Fig. 4(e)). No acute and chronic inflammatory infil-
trates or necrosis was seen in all rats.
Discussion
This present study demonstrated that the HFD intake
confirms induction of obesity in rats. Numerous com-
prehensive review of past studies have summarized high-
fat food significantly upsurge accumulation of adipose
tissue, due to their high energy density, leading to
increasing of body weight [31–33]. In this study, it was
observed that GBR treatment exerted beneficial effects
against obesity. Body weight gains and food intakes were
found to be significantly reduced in GBR administrated
obese rats (50 and 100 T), resulted in a reduction of the
Lee index and BMI. Similar results have been reported
by Ho et al. [9], in which mice supplemented with
0.15 % GBR methanol extract showed a significant re-
duction in their weight gain. However, they found no
significant reduction in food intake compared with un-
treated mice for 7 weeks. Oh et al. [10] also found a re-
duction in weight gain and food intake in mice fed with
10 μl/g body weight of GBR water extract for 8 weeks.
The differences between this present study and these
two previous studies are the approaches used, whereby
the GBR was given as a whole food after rats were in-
duced with obesity and further continued on HFD. Be-
sides, GBR was showed containing a significantly higher
amount of dietary fiber than white rice and brown rice
[18]. The bulking and viscosity properties of dietary fiber
are able to suppress food intake by promoting satiation
and satiety. Increasing efforts and/or time of mastication
in fiber-rich foods lead to increase satiety through a re-
duction in the rate of ingestion [34]. The promotion of
satiety by GBR, as a whole grain food, is elucidating the
reduction of food intake in GBR administrated obese
rats.
Apart from that, the treatment of GBR also signifi-
cantly lowered the plasma total cholesterol and triglycer-
ide levels. The HDL-cholesterol level showed a reduction
after administration of GBR. However, the percentage of
reduction in the HDL-cholesterol level was lesser in GBR
treated obese rats compared with untreated obese rats.
One of the possible reason for the reduction in HDL-
cholesterol level among GBR treated obese rats might be
due to the continuation feeding of HFD during the treat-
ment period as several studies showed that HFD resulted
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Fig. 2 Fecal fat content for obesity induction period and treatment period. Values are expressed as means ± SD (n = 3). Values with different
superscripts indicate significant difference (p < 0.05) by Duncan’s multiple range tests. NC, normal diet; PC, high-fat diet; 25 T, high-fat diet + 25 %




















Fig. 3 Photomicrographs of liver (Haematoxylin & Eosin, Original magnification x 100) of treated and untreated rats. a Normal liver in NC group.
b Diffuse micro- and macrovesicular steatosis, swollen hepatocytes, and hepatocyte necrosis was evidenced in PC group. c–e The treatments of
GBR reduced micro- and macrovesicular steatosis and other pathological features was witnessed in 25, 50 and 100 T group. H, Hepatocytes; MaV,
Macrovesicular; MiV, Microvesicular; N, Neutrophils; S, Sinusoids
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in dyslipidemic changes by increasing levels of triglyceride,
total cholesterol, LDL-cholesterol and reducing level of
HDL cholesterol [35, 36]. In addition, there were few stud-
ies reported similar results that GBR decreased the con-
centration of blood total cholesterol and triglycerides
compared with untreated HFD group [9, 10, 37]. Ho et al.
[9] postulated that the GABA, vitamin E, and γ-oryzanol
in GBR were the components that exerted hypocholester-
olemia in mice fed on HFD. Thus, this may explain why
the administration of GBR was found to be increased the
HTR but decreased the AI in GBR administrated obese
rats. Besides, the reduction of the total cholesterol and tri-
glyceride is also believed to be associated with dietary fi-
bers through the increment of steroid and bile acid
excretion into feces. Stronger bile acids binding ability of
rice bran compared with oat bran, wheat bran, and corn
bran has been reported [38]. The previous study hypothe-
sized the cholesterol-lowering mechanism of pre-GBR
might be due, at least in part, to the increment of steroid
and bile acid excretion into feces with an enhancement in
cholesterol 7α-hydroxylase activity in the liver microsomal
fraction [39].
In this study, administrated of GBR reduced levels of
leptin in the GBR administrated obese rats. It is more
likely that reduction of plasma leptin was due to the de-
creased of the white adipose tissue mass. This is because
blood leptin levels are closely related to fat deposition
[40]. Previous studies have shown similar results that de-
creased of fat mass resulted in a reduction in leptin con-
centrations [41, 42]. The results of this study indicated
that the administration of GBR resulted in decreased of
white adipose tissues. In addition, obesity is closely cor-
related with insulin resistance and hyperglycemia [43].
Surprisingly, the glucose levels of obese rats were not
significantly different than normal weight rats in this
Table 5 Histopathological scoring of liver in normal weight rats
and HFD-induced obese rats with and without treatment of
GBR for 8 weeks
Parametera NC PC 25 T 50 T 100 T
Hepatic steatosis
Microvesicular - +++ ++ ++ ++
Macrovesicular - +++ ++ ++ ++
Hepatitis - - - - -
Haemorrhage - - - - -
Hepatocyte necrosis - + - - -
Fat cysts - - - - -
Perivenular fibrosis - - - - -
NC normal diet, PC high-fat diet, 25 T high-fat diet + 25 % GBR, 50 T high-fat
diet + 50 % GBR, 100 T high-fat diet + 100 % GBR
aThe severity was evaluated based on the following scoring scheme: - normal,
+ mild effect, ++ moderate effect, +++ severe effect
Fig. 4 Photomicrographs of white adipose tissue (Haematoxylin & Eosin, Original magnification x 200) of treated and untreated rats. a Smaller
size of adipocytes was clearly observed in NC group. b Larger size of adipocytes was seen in PC group. The enlarged adipocytes might due to
coalescence of adjacent adipocytes cells. c–e The size of adipocytes in the obese rats treated with GBR was clearly smaller in 25, 50 and 100 T
group. A, Adipocytes; C, Blood capillaries; Co, Coalescence; N, Nucleus
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study. Other previous studies had also reported similar
findings in which they found no significant difference in
blood glucose between normal weight rats and obese
rats [13, 44]. However, they found insulin resistance in
obese rats. This is consistent with the notion that obesity
is often associated with insulin resistance [43]. On the
other hand, Imam et al. [17] reported a hypoglycemic ef-
fect of GBR on streptozotocin-induced diabetes rats.
Thus, further study is warranted to better elucidate the
effect of GBR on insulin resistance and hyperglycemia
under both physiological and pathophysiological
conditions.
In this present study, the GBR treatment enhanced the
fat excretion into feces in GBR administrated obese rats.
It is possible that anti-obesity effects of GBR, which
might account, at least partially resulted from suppress-
ing dietary fat digestion via inhibition of pancreatic lip-
ase activity with subsequent excretion of the undigested
fat, which was consistent with the findings of the in vitro
experiment [45]. Furthermore, this present study showed
a significant reduction in total white adipose tissue mass
(abdominal, epididymal and perirenal) and shrinkage in
adipocytes in GBR fed obese rats. It is plausible that
GBR exerts its anti-obesity effects by decreasing fat ac-
cumulation through inhibiting adipocyte differentiation
and stimulating lipolysis on adipocytes as reported in
the in vitro study [45]. This is further supported by the
down-regulated expression of adipogenic transcription
factors and adipogenic genes in 3T3-L1 adipocytes stud-
ied in GBR extract previously [9]. Moreover, micro- and
macrovesicular steatosis was evidently attenuated in
GBR treated obese rats. The consumption of HFD con-
tributed to obesity, which is increased the risk of nonal-
coholic fatty liver disease in obese individuals [46].
Steatosis, the hallmark of a feature of the nonalcoholic
fatty liver disease, progresses to steatohepatitis, eventu-
ally to cirrhosis [47]. The treatment of GBR results in a
reduction of steatosis, suggesting the potential role of
GBR in restoring the liver damage caused by HFD.
Conclusions
In conclusion, this study provides evidence that GBR ame-
liorates obesity by suppressing body weight gain and food
intake while improving lipid profiles and reducing leptin
level and white adipose tissue mass in obese rats fed on
HFD. The beneficial effects of GBR on obesity seem to be
partly attributed to the synergistic effects of its high
dietary fibers, vitamins, minerals and other bioactive
compounds such as GABA, γ-oryzanol, phytosterols, poly-
phenols, tocotrienols and α-tocopherol. However, further
studies are required to verify the effectiveness of GBR in
fighting obesity in human study and to recommend the
dosage to use GBR in the daily diet.
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